Timing of surgery following <scp>SARS‐CoV</scp>‐2 infection: an ever‐changing landscape

Reynolds, Ian S.; Ryan, Éanna J; Martin, Silvia

doi:10.1111/anae.15673

Cited by 2 publications

(4 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[3][4][5][6] SARS-CoV-2 infection may therefore be associated with increased risk of adverse outcomes following elective surgery. 7 There is an urgent need for evidence to inform preoperative risk assessment, as it is critical to surgical care planning and to informing patient consent. Several prior studies [8][9][10][11][12][13] found that SARS-CoV-2 infection prior to elective or emergency surgery was associated with a greater risk of adverse outcomes.…”

Section: Introductionmentioning

confidence: 99%

“… 3 , 4 , 5 , 6 SARS-CoV-2 infection may therefore be associated with increased risk of adverse outcomes following elective surgery. 7 …”

Section: Introductionmentioning

confidence: 99%

“…SARS-CoV-2 infection is associated with increased risk of cardiovascular disease and venous thromboembolism, and many people who survive infection with SARS-CoV-2 have reduced functional reserve and are at increased risk of death . SARS-CoV-2 infection may therefore be associated with increased risk of adverse outcomes following elective surgery …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Complications Following Elective Major Noncardiac Surgery Among Patients With Prior SARS-CoV-2 Infection

et al. 2022

View full text Add to dashboard Cite

ImportanceThere is an urgent need for evidence to inform preoperative risk assessment for the millions of people who have had SARS-CoV-2 infection and are awaiting elective surgery, which is critical to surgical care planning and informed consent.ObjectiveTo assess the association of prior SARS-CoV-2 infection with death, major adverse cardiovascular events, and rehospitalization after elective major noncardiac surgery.Design, Setting, and ParticipantsThis population-based cohort study included adults who had received a polymerase chain reaction test for SARS-CoV-2 infection within 6 months prior to elective major noncardiac surgery in Ontario, Canada, between April 2020 and October 2021, with 30 days follow-up.ExposuresPositive SARS-CoV-2 polymerase chain reaction test result.Main Outcomes and MeasuresThe main outcome was the composite of death, major adverse cardiovascular events, and all-cause rehospitalization within 30 days after surgery.ResultsOf 71 144 patients who underwent elective major noncardiac surgery (median age, 66 years [IQR, 57-73 years]; 59.8% female), 960 had prior SARS-CoV-2 infection (1.3%) and 70 184 had negative test results (98.7%). Prior infection was not associated with the composite risk of death, major adverse cardiovascular events, and rehospitalization within 30 days of elective major noncardiac surgery (5.3% absolute event rate [n = 3770]; 960 patients with a positive test result; adjusted relative risk [aRR], 0.91; 95% CI, 0.68-1.21). There was also no association between prior infection with SARS-CoV-2 and postoperative outcomes when the time between infection and surgery was less than 4 weeks (aRR, 1.15; 95% CI, 0.64-2.09) or less than 7 weeks (aRR, 0.95; 95% CI, 0.56-1.61) and among those who were previously vaccinated (aRR, 0.81; 95% CI, 0.52-1.26).Conclusions and RelevanceIn this study, prior infection with SARS-CoV-2 was not associated with death, major adverse cardiovascular events, or rehospitalization following elective major noncardiac surgery, although low event rates and wide 95% CIs do not preclude a potentially meaningful increase in overall risk.

show abstract

Section: Introductionmentioning

confidence: 99%

“… 3 , 4 , 5 , 6 SARS-CoV-2 infection may therefore be associated with increased risk of adverse outcomes following elective surgery. 7 …”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Complications Following Elective Major Noncardiac Surgery Among Patients With Prior SARS-CoV-2 Infection

et al. 2022

View full text Add to dashboard Cite

show abstract

“…6 SARS CoV-2 infekcija povećava rizik nastanka kardiovaskularnih bolesti i venske tromboembolije [7][8][9] i može biti povezana s lošim ishodom nakon planiranih operacijskih zahvata. 10 Nameće se pitanje je li potreban prijeoperacijski screening za utvrđivanje SARS CoV-2 infekcije. Ako utvrdimo da bolesnik ima infekciju, je li potrebna odgoda operacije i ako jest koliko dugo?…”

unclassified

Clostridial gas gangrene after laparoscopic cholecystectomy: the role of SARS-CoV-2 virus – a case report and review of literature

2023

View full text Add to dashboard Cite

Timing of surgery following SARS‐CoV‐2 infection: an ever‐changing landscape

Abstract: Reports of excess mortality, pulmonary complications and thromboembolic events in patients undergoing surgery with a peri-operative diagnosis of SARS-CoV-2 prompted

Cited by 2 publications

References 4 publications

Complications Following Elective Major Noncardiac Surgery Among Patients With Prior SARS-CoV-2 Infection

Complications Following Elective Major Noncardiac Surgery Among Patients With Prior SARS-CoV-2 Infection

Clostridial gas gangrene after laparoscopic cholecystectomy: the role of SARS-CoV-2 virus – a case report and review of literature

Contact Info

Product

Resources

About